Ratna B. Ray, Ranjit Ray – 13 August 2018 – Chronic hepatitis C virus (HCV) infection‐associated liver disease is a global health problem. HCV often causes silent disease, and eventually progresses to end‐stage liver disease. HCV infects hepatocytes; however, initial manifestation of liver disease is mostly displayed in hepatic stellate cells (HSCs), causing fibrosis/cirrhosis, and is believed to occur from inflammation in the liver.

10 August 2018

Zaid H. Tafesh, Robert S. Brown, Nicholas Russo, Russell Rosenblatt, Aleksey Novikov, Robert E. Schwartz, Joseph F. Pisa, Nicole T. Shen, Vikas Gupta, Shirley Cohen‐Mekelburg – 10 August 2018

10 August 2018

Zaid H. Tafesh, Robert S. Brown, Nicholas Russo, Russell Rosenblatt, Aleksey Novikov, Robert E. Schwartz, Joseph F. Pisa, Nicole T. Shen, Vikas Gupta, Shirley Cohen‐Mekelburg – 10 August 2018

10 August 2018

10 August 2018

10 August 2018

10 August 2018

Uchenna Agbim, Yu Jiang, Satish K. Kedia, Ashwani K. Singal, Aijaz Ahmed, Kalyan Ram Bhamidimarri, David E. Bernstein, Stephen A. Harrison, Zobair M. Younossi, Sanjaya K. Satapathy – 9 August 2018 – Nonalcoholic fatty liver disease is an increasingly prevalent condition, and its more severe progressive state, nonalcoholic steatohepatitis (NASH), is currently the second most common indication for wait‐listed adults in the United States.